Innovative Solutions for Fast-Tracking Drugs for Rare Diseases

By attending this webinar, you will learn what works and what doesn’t in our rapidly changing regulatory and reimbursement world. Oliver Leatham, Vice President, Global Value & Access at Certara, will discuss the following:

  • Case studies of approved drugs with limited market access – What went wrong?
  • Analogues of products that have successfully navigated the reimbursement landscape using innovative contracting
  • How RWE can support payer confidence and market access to sustain premium pricing and drive market share
  • How sponsors are approaching the changing regulatory and reimbursement environment to stay ahead of the competition
Speaker(s): Oliver Leatham
Date: August 7th, 2019
Time: 11:00 am ET
Duration: 1 hour
Fill out the form to register now!

*If you are unable to register for this webinar because your business email is a free/POP3 address, please email [email protected] and we will register you.